237 related articles for article (PubMed ID: 24032643)
1. Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review.
Bizzarri M; Proietti S; Cucina A; Reiter RJ
Expert Opin Ther Targets; 2013 Dec; 17(12):1483-96. PubMed ID: 24032643
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells.
Cucina A; Proietti S; D'Anselmi F; Coluccia P; Dinicola S; Frati L; Bizzarri M
J Pineal Res; 2009 Mar; 46(2):172-80. PubMed ID: 19175854
[TBL] [Abstract][Full Text] [Related]
3. SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells.
Cheng Y; Cai L; Jiang P; Wang J; Gao C; Feng H; Wang C; Pan H; Yang Y
Eur J Pharmacol; 2013 Sep; 715(1-3):219-29. PubMed ID: 23726949
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
5. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
6. Oncostatic action of melatonin: facts and question marks.
Pawlikowski M; Winczyk K; Karasek M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():24-9. PubMed ID: 12019348
[TBL] [Abstract][Full Text] [Related]
7. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects.
Carrillo-Vico A; Lardone PJ; Naji L; Fernández-Santos JM; Martín-Lacave I; Guerrero JM; Calvo JR
J Pineal Res; 2005 Nov; 39(4):400-8. PubMed ID: 16207296
[TBL] [Abstract][Full Text] [Related]
8. Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells.
Sánchez-Sánchez AM; Martín V; García-Santos G; Rodríguez-Blanco J; Casado-Zapico S; Suarez-Garnacho S; Antolín I; Rodriguez C
Free Radic Res; 2011 Nov; 45(11-12):1333-41. PubMed ID: 21923620
[TBL] [Abstract][Full Text] [Related]
9. Melatonin in cancer management: progress and promise.
Jung B; Ahmad N
Cancer Res; 2006 Oct; 66(20):9789-93. PubMed ID: 17047036
[TBL] [Abstract][Full Text] [Related]
10. Pro-oxidant effect of melatonin in tumour leucocytes: relation with its cytotoxic and pro-apoptotic effects.
Bejarano I; Espino J; Barriga C; Reiter RJ; Pariente JA; Rodríguez AB
Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):14-20. PubMed ID: 20649556
[TBL] [Abstract][Full Text] [Related]
11. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
Li L; Zhu Z; Joshi B; Porter AT; Tang DG
Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
[TBL] [Abstract][Full Text] [Related]
12. Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines.
Sánchez-Hidalgo M; Lee M; de la Lastra CA; Guerrero JM; Packham G
J Pineal Res; 2012 Nov; 53(4):366-73. PubMed ID: 22582944
[TBL] [Abstract][Full Text] [Related]
13. Melatonin: the smart killer: the human trophoblast as a model.
Lanoix D; Lacasse AA; Reiter RJ; Vaillancourt C
Mol Cell Endocrinol; 2012 Jan; 348(1):1-11. PubMed ID: 21889572
[TBL] [Abstract][Full Text] [Related]
14. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1).
Leja-Szpak A; Jaworek J; Pierzchalski P; Reiter RJ
J Pineal Res; 2010 Oct; 49(3):248-55. PubMed ID: 20626591
[TBL] [Abstract][Full Text] [Related]
15. Melatonin as a promising agent to treat ovarian cancer: molecular mechanisms.
Chuffa LGA; Reiter RJ; Lupi LA
Carcinogenesis; 2017 Oct; 38(10):945-952. PubMed ID: 28575150
[TBL] [Abstract][Full Text] [Related]
16. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.
Tomek M; Akiyama T; Dass CR
J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions.
Cos S; González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ
Cancer Detect Prev; 2006; 30(2):118-28. PubMed ID: 16647824
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells.
Wang J; Xiao X; Zhang Y; Shi D; Chen W; Fu L; Liu L; Xie F; Kang T; Huang W; Deng W
J Pineal Res; 2012 Aug; 53(1):77-90. PubMed ID: 22335196
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells.
Gatti G; Lucini V; Dugnani S; Calastretti A; Spadoni G; Bedini A; Rivara S; Mor M; Canti G; Scaglione F; Bevilacqua A
Oncotarget; 2017 Sep; 8(40):68338-68353. PubMed ID: 28978121
[TBL] [Abstract][Full Text] [Related]
20. Role of melatonin in cancer treatment.
Cutando A; López-Valverde A; Arias-Santiago S; DE Vicente J; DE Diego RG
Anticancer Res; 2012 Jul; 32(7):2747-53. PubMed ID: 22753734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
